[ad_1] The California Supreme Court struck down the controversial initiative to appear on the November bulletin in a unanimous decision, writing that "important issues have been raised regarding the validity of the …
Read More »They order to withdraw from the market drugs with valsatran, in case of possible carcinogenic impurity
[ad_1] The Directorate General of Drugs, Supplies and Medicines (Digemid) of the Ministry of Health (Minsa) ordered the withdrawal of 33 products containing valsartan (active ingredient used for arterial hypertension) in response …
Read More »